Dr. Shamil Patel Discusses the Role of Canaloplasty Across the Full Spectrum of Glaucoma скачать в хорошем качестве

Dr. Shamil Patel Discusses the Role of Canaloplasty Across the Full Spectrum of Glaucoma

Can MIGS options such as canaloplasty work for patients with severe glaucoma? Expert Dr. Shamil Patel (United States) says yes—and in this video, he sets out to prove it. Previously, MIGS was performed to bridge the treatment gap between medications in early stage disease, and invasive surgical options such as trabeculectomy for severe disease. Following the results of his retrospective study which investigated the clinical outcomes of canaloplasty with iTrack™ Advance across the full spectrum of glaucoma, Dr. Patel is challenging the notion that MIGS should only be used in cases of early disease. Instead, he recommends that, based on its comprehensive mechanism of action which aims to truly restore physiological outflow, canaloplasty can offer significant utility in cases of severe disease. See the data. Watch now. This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore. The iTrack™ Advance has a US Food and Drug Administration (FDA) 510(k) and CE Mark (Conformité Européenne) for the treatment of open-angle glaucoma. Indications for Use, USA: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. The ab interno surgical technique is not a cleared indication for the iTrack™ Advance in the USA. The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma. Indications for Use, International: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. For more information in relation to approved labelling and indications for use, please visit https://itrack-advance.com/